Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
INTERVENTIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
NCT02951351
An Evaluation of the Safety and Efficacy of FID 114657
NCT01030237
Effect of Intraoperative Dexamethasone on Post-op Dry Eye
NCT04184999
Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery
NCT00909324
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
NCT00520260
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polyethylene Glycol 400 0.4%
Propylene Glycol 0.3%
0.15% sodium Hyaluronate
sodium chloride
sodium phosphate monobasic
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Males or females
3. Any race or ethnic background
4. Patients with present ocular surface discomfort and a SESoD score of at least 2
Exclusion Criteria
2. Contact lens use on day of examination.
3. Corneal ectasia.
4. Current use of Restasis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innovative Medical
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tom Kislan, OD
Role: PRINCIPAL_INVESTIGATOR
Hazleton Eye Specialists
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hazleton Eye Specialists
Hazleton, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5310
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.